CStone Pharmaceuticals sees boost in issued shares after option exercises

CStone Pharmaceuticals reported a notable increase in its total issued share capital for the month ended September 30, 2025. The company's total number of issued shares rose by 8,820,855 to 1,475,977,923 from 1,467,157,068 shares at the close of the preceding month. This increase was primarily driven by the exercise of share options under two schemes.

Under the Pre-IPO Incentivization Plan, 3,220,000 new shares were issued during the month, reducing outstanding options from 4,395,618 to 1,175,618. Additionally, the Post-IPO Employee Share Option Plan saw 5,600,855 new shares issued, decreasing outstanding options from 96,172,855 to 90,536,774. A further 35,226 options under this plan lapsed.

The total funds raised from the exercise of these options during the month amounted to HK$14,609,671.56. The company’s authorized/registered share capital remained unchanged at 2,000,000,000 shares, with a par value of $0.0001, totaling $200,000.